| Regional variation in health care utilization in Sweden–the importance of demand-side factors N Johansson, N Jakobsson, M Svensson BMC health services research 18, 1-9, 2018 | 41 | 2018 |
| Effects of primary care cost-sharing among young adults: varying impact across income groups and gender N Johansson, N Jakobsson, M Svensson The European Journal of Health Economics 20 (8), 1271-1280, 2019 | 25 | 2019 |
| Reductions in out-of-pocket prices and forward-looking moral hazard in health care demand N Johansson, SC de New, JS Kunz, D Petrie, M Svensson Journal of health economics 87, 102710, 2023 | 15 | 2023 |
| Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits? G Chauca Strand, N Johansson, N Jakobsson, C Bonander, M Svensson Clinical drug investigation 43 (8), 621-633, 2023 | 9 | 2023 |
| Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs GC Strand, C Bonander, N Jakobsson, N Johansson, M Svensson ESMO open 7 (5), 100569, 2022 | 8 | 2022 |
| Regional variation in prescription drug spending: Evidence from regional migrants in Sweden N Johansson, M Svensson Health Economics 31 (9), 1862-1877, 2022 | 4 | 2022 |
| Lifetime healthcare expenditures across socioeconomic groups in Sweden S Fledsberg, M Svensson, N Johansson European Journal of Public Health 33 (6), 994-1000, 2023 | 3 | 2023 |
| Vad kan förklara regionala skillnader i svensk hälso-och sjukvård N Johansson Rapport från SNS Analys, 2021 | 3 | 2021 |
| Reproduction and replication analyses of Andersson (2019): A replication report from the Toronto Replication Games C Bonander, N Jakobsson, N Johansson I4R Discussion Paper Series, 2023 | 2 | 2023 |
| Place or patient as the driver of regional variation in healthcare spending–Discrepancies by category of care N Johansson, N Jakobsson, M Svensson Social Science & Medicine 342, 116571, 2024 | 1 | 2024 |
| Price sensitivity and regional variation in health care N Johansson | 1 | 2021 |
| Analyses of quality of life in cancer drug trials-a review of measurements and analytical choices in post-reimbursement studies M Svensson, GC Strand, C Bonander, N Johansson, N Jakobsson BMC cancer 24 (1), 311, 2024 | | 2024 |
| PCR221 Measurement and Analysis of Health-Related Quality of Life Data in Cancer Drug Trials: A Review of Post-Reimbursement Data M Svensson, GC Strand, C Bonander, N Johansson, N Jakobsson Value in Health 26 (6), S353, 2023 | | 2023 |
| Healthcare cost consequences of changing diagnostic criteria for gestational diabetes mellitus (CDC4G) in Sweden: Alongside a stepped wedge cluster randomised trial M de Brun, N Johansson, D Simmons, S Montgomery, K Berntorp, ... | | 2023 |
| What explains regional differences in Swedish healthcare? Naimi Johansson N Johansson | | |
Mikael SvenssonProfessor, University of FloridaDirección de correo verificada de gu.se